Purine biosynthesis by the 'de novo' pathway was demonstrated in isolated rat extensor digitorum longus muscle with [1-14C]glycine, [3-14C]serine and sodium [14C]formate as nucleotide precursors. Evidence is presented which suggests that the source of glycine and serine for purine biosynthesis is extracellular rather than intracellular. The relative incorporation rates of the three precursors were formate > glycine > serine. Over 85% of the label from formate and glycine was recovered in the adenine nucleotides, principally ATP. Azaserine markedly inhibited purine biosynthesis from both formate and glycine. Cycloserine inhibited synthesis from serine, but not from formate. Adenine, hypoxanthine and adenosine markedly inhibited purine synthesis from sodium [14Clformate.
Purine nucleotides can be synthesized by two pathways, the 'de novo' pathway, which predominantly uses amino acids, and the salvage pathway, which uses preformed purine bases and nucleosides. Tissues appear to differ in their capacities to synthesize nucleotides by one or both of these pathways. Murray (1971) commented that there was no information on whether muscle tissue can synthesize purines de novo or whether depleted nucleotide pools must be replenished by purine salvage. McKeran & Watts (1978) noted that the importance in muscle of purine biosynthesis de novo remained to be established. In preliminary reports, evidence for the ability of rat extensor digitorum longus muscle to synthesize purine nucleotides by the 'de novo' pathway was presented (Sheehan et al., 1977; Tully & Sheehan, 1980) . A full account of this work is presented here.
Work with primary rat muscle cell cultures supports the conclusion that skeletal muscle utilizes the 'de novo' pathway for purine nucleotide synthesis (Brosh et al., 1982; Zoref-Shani et al., 1982) . Interest in the study of muscle purine metabolism has been stimulated by the suggestion that allopurinol, a xanthine oxidase inhibitor, improves patients with Duchenne muscular dystrophy (Thomson & Smith, 1978) , and also by the report of a muscle adenylate deaminase deficiency associated with skeletal-muscle dysfunction (Fishbein et al., 1978) .
* To whom reprint requests should be addressed.
Materials and methods

Materials
Isotopically labelled compounds were supplied by The Radiochemical Centre, Amersham, Bucks., U.K. Polygram Cel 300 poly(ethyleneimine)-cellulose thin-layer plates were from Macherey, Nagel and Co., Diiren, Germany. Chromagram cellulose thin-layer plates were obtained from Eastman Kodak Co., Rochester, NY, U.S.A., and DEAE-cellulose paper was from W. and R. Balston, Maidstone, Kent, U.K. Albino rats (70-90g) of the Wistar strain obtained from the University animal house were used. The animals were fed on standard rat pellets (Livestock Foods Ltd., Dublin, Ireland), and were allowed food ad libitum. Both male and female rats were used, as sex differences did not affect the results obtained.
Isolated muscle preparation
Rat extensor digitorum longus muscle was used. The animals were anaesthetized with pentobarbitone sodium (50mg/kg), and the muscles, weighing between 25 and 35 mg, were removed. Muscles of this size were selected since the oxygen uptake during incubation becomes critical if larger muscles are used (Fern et al., 1971) . Both the dry and wet muscle weights were directly proportional to the weight of the whole rat. The relationship Rat weight (g) = 2.3 muscle weight (mg) + 9
gave a correlation coefficient of 0.92 for 25 rats.
This avoided the necessity for direct weighing of the Vol. 216 muscle. Owing to its small size, four muscles were used in each incubation, so that changes in metabolite concentration could be measured more accurately. Details of the incubation are given by Sheehan et al. (1977) .
Extraction ofpurines Muscles were removed from the incubation medium, quickly rinsed in cold physiological saline (0.9% NaCl), and freeze-clamped with a clamp pre-cooled in liquid N2. The frozen tissue was placed in a plastic centrifuge tube filled with liquid N2 and ground to a powder with a round-ended steel rod. The residual liquid N2 was allowed to evaporate. After addition of 0.5 ml of 0.92 M-HCl04, the suspension was homogenized for 15 s with an Ultra-Turrax TP 18/10 blender, and centrifuged at 4000g for 5min. The suspension was then centrifuged at 4000g for 5min at 40C, and the supernatant neutralized with cold KOH, saturated with KCl. KCl saturation ensured that KCl04 concentration was minimized by the common-ion effect (Buckley & Williamson, 1977) . The neutralized extract was left at 0°C for 20min to allow full precipitation of the KCG04, after which it was centrifuged at i5OOg for 5min at 40C. The extract was analysed immediately after preparation.
Separation ofpurine nucleotides
Purine nucleotides were separated by t.l.c. on poly(ethyleneimine)-cellulose-plates (Henderson et al., 1974 (Burridge et al., 1977) . Detection and quantification oflabelledpurines after chromatography After chromatography, purine spots were located under u.v. light, and circled with a pin. Nucleotide spots were moistened with 1.5M-NaCl with a lOpl Drummond 'microcap' pipette, removed from the plastic backing with a spatula, and transferred quantitatively to vials for radioactivity counting. Purine bases and nucleosides were treated similarly, except that the spots were moistened with 0.05M-Tris/HCl, pH 7.0. The composition of the scintillation fluid was 5.Og of 2,5-diphenyloxazole, 0.5g of 1,4-bis-(5-phenyloxazol-2-yl)benzene and 330ml of Triton X-100 made up to 1 litre with toluene. The radioactivity was measured in a Beckman LS-1OOC liquid-scintillation counter.
Measurement of amino acids in muscle and incubation medium Analysis was performed by a modification of the g.l.c. method of Gehrke & Leimer (1971) , which consisted of adjusting the initial temperature, holding time and temperature-gradient rate, to decrease the separation time from 42 to 18 min. Interfering substances were removed by the method of Zumwalt et al. (1970) . The amino acid trimethylsilyl derivatives were separated in a Perkin-Elmer Sigma 3B temperature-programmed gas chromatograph, equipped with a two-column oven and two flame ionization detectors.
Results
Viability ofmuscle preparation
In a preliminary report, evidence was presented that the isolated extensor digitorum longus muscle remained viable over a 60min incubation period (Sheehan et al., 1977) . The criteria employed were glucose uptake, lactate release and intracellular concentrations of AMP, ADP, ATP and K+. As experiments involving incubation periods of up to 3 h were performed, viability studies were extended over that period. In addition to the previous criteria used, phosphocreatine concentrations, muscle weight, water content and extracellular space were determined. All criteria indicated a viable muscle preparation over the 3 h incubation period.
Purine biosynthesis from labeledprecursors
Purine biosynthesis by the 'de novo' pathway was demonstrated by the use of [ 1-'4C]glycine and [3-14Clserine as precursor molecules (Fig. 1) . The extensor digitorum longus muscle excreted glycine and serine into the incubation medium, so the specific radioactivities of those amino acids both intracellularly and in the medium were monitored over the incubation period. The values obtained were used to calculate the mean specific radioactivities of both amino acids in the muscle and medium (Zimmer et al., 1973) . The mean specific radioactivities were then employed to calculate the rates of purine synthesis from the two amino acids. The 1983 (Henderson, 1972 Effects of azaserine and cycloserine on incorporation of labelled precursors of the 'de novo' pathway Azaserine (O-diazoacetyl-L-serine) inhibits purine biosynthesis by the 'de novo' pathway, acting as a classical competitive inhibitor because of its structural resemblance to glutamine (Henderson & Paterson, 1973) . Azaserine markedly inhibited labelling of purines by both glycine and formate. The inhibition was decreased in the presence of glutamine (Table 4) .
At 5 mm, cycloserine (D-4-amino-3-isoxazolidinone), which inhibits serine hydroxymethyltransferase, decreased labelling of purine nucleotides from [3-14C]serine by 40%, but had no effect on purine 1983 shown). The inhibitor had no effect on serine uptake by muscle.
Effects of adenine, hypoxanthine and adenosine on purine synthesisfrom sodium ['4C]formate Table 5 shows the effects of these purines on sodium [14C]formate incorporation into purines:
with the exception of adenosine at the lower concentration, all purines showed marked inhibition.
Discussion Brosh et al. (1982) reported that sodium [14C]-formate was incorporated into purines by both myoblast and primary muscle cultures from the rat. The same authors also demonstrated synthesis de novo of purine nucleotides in muscles of mice injected with sodium [14Clformate. Zoref-Shani et al. (1982) also provided evidence for purine nucleotide synthesis in primary rat muscle cultures, and showed that the rate of formate incorporation was dependent upon cellular availability of 5-phosphoribosyl 1-pyrophosphate.
The results presented here show clearly that the isolated extensor digitorum longus muscle of the rat can synthesize purine nucleotides by the 'de novo' pathway. Partial supporting evidence was presented previously (Sheehan et al., 1977) .
Three precursors of purine nucleotide synthesis by the 'de novo' pathway, glycine, serine and formate, were shown to be incorporated into the purines of the extensor digitorum longus muscle ( Fig. 1 and Table 3 ). Table 1 shows that the rate of purine synthesis from glycine fell dramatically over a 60min incubation when the mean specific radioactivity of intracellular glycine was used in the calculation, but this is at variance with the linear rate of glycine incorporation over 60min shown in Fig. 1 . The rates calculated from the mean specific-radioactivity values of extracellular glycine are more in agreement. Other workers have failed to observe a direct relationship between the intracellular glycine pool and the rate of protein synthesis (Kipnis et al., 1961; Manchester & Wool, 1963; Rosenberg & Holmsen, 1968; Roscoe et al., 1968) . Banos et al. (1973) reported that the entry of amino acids into rat skeletal muscle takes place by carrier-mediated transport processes with a high degree of specificity. They proposed a model for amino acid utilization for protein synthesis which, if applied to purine nucleotide synthesis, would explain how extracellular glycine could be preferentially incorporated into purines. In this model the amino acid carrier has two possible routes. The first is to enter the intracellular pool, followed by dissociation to the free amino acid and carrier. The second involves conjugation with ATP or some other molecule, with subsequent removal for protein synthesis. The results obtained with serine also suggest that extracellular serine is used for purine synthesis in muscle ( Fig. 1 and Table  2 ).
The approximate rate for the three precursors over 60 min varied from 8 nmol/g for serine to 10nmol/g for glycine to 28nmol/g for formate.
Detailed studies of the rates of purine nucleotide synthesis in skeletal muscle have not been made, but Zimmer et al. (1973) reported a rate of 8.4 + 1.42 nmol/h per g for the rate of synthesis of adenine nucleotides de novo in rat heart in situ. Table 3 shows that use of either labelled glycine or formate as precursors of purine synthesis resulted in approx. 85% of the label being recovered in adenine-containing compounds. A similar pattern was obtained in cultured human fibroblasts by Zoref & Sperling (1980) and by Zoref et al. (1978) . Surprisingly, using rat muscle cultures Zoref-Shani et al. (1982) found that over 50% of labelled formate was recovered by hypoxanthine-containing compounds. The higher recovery of labelled formate in hypoxanthine-containing compounds in muscle cultures reflects either a decreased incorporation into the adenine and guanine nucleotides, or a higher rate of catabolism of the adenine nucleotides in this preparation, which may render it a less adequate physiological model. Table 4 shows that azaserine inhibited the utilization of labelled formate and glycine for purine synthesis. The dose required for 90% inhibition was greater than that required for 90% inhibition in mouse liver, kidney, lung, intestine and spleen (Moore & Le Page, 1957) . The greater tolerance of skeletal muscle to azaserine could be due to the high concentration in this tissue of glutamine (Garber et Vol. 216 al., 1976) , which has a protective effect against azaserine (Levenberg et al., 1957; Chu & Henderson, 1972) . The addition of glutamine with azaserine modified the inhibition, although glutamine alone did not stimulate purine biosynthesis de novo in extensor digitorum longus, unlike in some cells, where it is reported to be rate limiting (Henderson, 1962; Fontenelle & Henderson, 1969) . Table 4 shows that the lower concentration of azaserine used did not affect the concentration of ATP, but 10mM-azaserine decreased ATP by 15%. Marchetti et al. (1970) found no change in rat liver ATP concentrations after treatment with azaserine, but Hyams et al. (1967) reported a 37% decrease in ATP with a higher azaserine concentration.
Cycloserine, an inhibitor of serine hydroxymethyltransferase, lowered the rate of purine biosynthesis de novo from [3-14C] serine, but did not affect the incorporation of sodium [14C]formate (Table 4) .
Adenine, adenosine and hypoxanthine inhibited purine biosynthesis de novo (Table 5) . Similar results were reported by Zoref-Shani et al. (1982) with primary rat muscle cultures from extensor digitorum longus, by Gordon et al. (1980) with human fibroblasts, by Hershfield & Seegmiller (1976) with human lymphoblasts and by Badenoch-Jones & Buttery (1976) with chicken liver and kidney. At the concentrations used, none of the purines affected the relative proportion of IMP converted into adenine and guanine nucleotides (results not shown). Hershfield & Seegmiller (1976) , using concentrations of adenine that inhibited the 'de novo' pathway by less than 40% in human lymphoblasts, found that adenine selectively inhibited adenine nucleotide synthesis, while stimulating guanine nucleotide synthesis to a lesser extent.
